Enthesis healing
US-2024390292-A1 · Nov 28, 2024 · US
US9636109B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9636109-B2 |
| Application number | US-50763509-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 22, 2009 |
| Priority date | Jul 22, 2009 |
| Publication date | May 2, 2017 |
| Grant date | May 2, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure generally relates to biodegradable and bioresorbable materials having a mineral layer on the surface of the material. More particularly, the disclosure relates to biodegradable and bioresorbable orthopedic devices having a degradable mineral layer on the surface thereof that can be used as a delivery vehicle for biological substances. Also provided are various methods of using the mineralized devices in tissue regeneration, including bone tissue engineering, and methods for producing the mineralized devices.
Opening claim text (preview).
What is claimed is: 1. A biologically active suture comprising: a suture material comprising one or more filaments, wherein a surface of the suture material is chemically hydrolyzed and comprises heterogeneous mineral nucleation sites thereon; at least one degradable mineral layer associated with the surface of the suture material; and at least one biological substance associated with the degradable mineral layer. 2. The suture of claim 1 wherein the suture material is bioresorbable. 3. The suture of claim 1 wherein the degradable mineral layer comprises a mineral selected from the group consisting of hydroxyapatite, α-tricalcium phosphate, β-tricalcium phosphate, amorphous calcium phosphate, dicalcium phosphate, octacalcium phosphate, calcium carbonate, calcium sulfate, and combinations thereof. 4. The suture of claim 1 comprising at least a first biological substance and a second biological substance. 5. The suture of claim 4 wherein the first biological substance and the second biological substance are associated with the same region of the degradable mineral layer. 6. The suture of claim 4 wherein the first biological substance and the second biological substance are associated with different regions of the degradable mineral layer. 7. The suture of claim 6 wherein the different regions are alternating regions. 8. The suture of claim 1 wherein the suture comprises a first degradable mineral layer associated with the surface of the suture material and at least a second degradable mineral layer associated with a surface of the first degradable mineral layer. 9. The suture of claim 8 wherein the at least one biological substance is associated with the first degradable mineral layer, the second degradable mineral layer, or combinations thereof. 10. The suture of claim 8 wherein the second degradable mineral layer is not associated with a biological substance.
Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)} · CPC title
containing a biologically active substance, e.g. a medicament or a biocide · CPC title
Phosphorus-containing materials, e.g. apatite · CPC title
Sutures (suture materials A61L17/00; manufacture of artificial threads D01D; treatment of threads D06M) · CPC title
Materials at least partially resorbable by the body · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.